Johnson & Johnson (JNJ) News Headlines

▮ More

Date

Headline

12/8/2019 9:55:21 PM Janssen To Buy Investigational Bermekimab From XBiotech

12/5/2019 4:18:18 PM Johnson & Johnson Names Hubert Joly And Mark Weinberger To Its Board Of Directors

11/21/2019 10:31:08 AM J&J Subsidiary Ethicon Loses Class Action Suit In Australia

10/31/2019 5:12:04 PM Ethicon Recalls ECHELON FLEX ENDOPATH Staplers

10/30/2019 9:56:02 AM Johnson & Johnson Says New Tests Found No Asbestos In Baby Powder

10/18/2019 8:55:44 AM Johnson & Johnson Consumer Recalls Single Lot Of Baby Powder In U.S.

10/18/2019 8:41:08 AM Johnson & Johnson Recalls A Single Lot Of Baby Powder In U.S.

10/18/2019 7:35:01 AM J&J Offers $4 Bln, Teva $15 Bln To Settle Opioid Claims Ahead Of Trial

10/17/2019 12:36:24 PM Johnson & Johnson (JNJ) Declares $ 0.95 Dividend for Q4 19, Record Date 11/26/2019

10/17/2019 11:51:56 AM Johnson & Johnson Declares Quarterly Dividend Of $0.95/share, Payable Dec. 10/ Record Nov. 26

10/16/2019 8:16:08 AM Missouri Appeals Court Reverses $110 Mln Talc Verdict Against J&J

10/15/2019 10:26:00 PM Major Drug Distributors In Talks To Settle Opioid Litigation For $18 Bln : WSJ

10/15/2019 7:30:10 AM Johnson & Johnson Q3 19 Earnings Conference Call At 8:30 AM ET

10/15/2019 7:00:00 AM Johnson & Johnson Boosts FY19 Outlook - Quick Facts

10/15/2019 6:54:57 AM Johnson & Johnson (JNJ) Has Raised Its FY19 Revenue Estimate To $83.7 - $84.2 Bln From $82.4 - $83.2 Bln

10/15/2019 6:54:21 AM Johnson & Johnson (JNJ) Has Raised Its FY19 EPS Estimate To 8.62 - 8.67 From 8.53 - 8.63

10/15/2019 6:50:05 AM Johnson & Johnson Q3 adjusted earnings Beat Estimates

10/15/2019 6:45:07 AM Johnson & Johnson Q3 EPS $1.81; Adj EPS $2.12

10/15/2019 1:41:02 AM RETA Surges On Trial Data, RVNC On Track, All Eyes On RLMD Today

10/8/2019 9:55:12 PM J&J Ordered To Pay $8 Bln In Case Over Male Breast Growth On Anti-psychotic Drug